Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2025 Earnings Call Transcript
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2025 Earnings Call Transcript August 6, 2025Lexicon Pharmaceuticals, Inc. beats earnings expectations.
Lexicon Pharmaceuticals Inc. (LXRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 38,918,903 | $36,805,607 | 1.9% | |
| 2. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 4,576,152 | $4,327,663 | -45% | 0.03% |
| 3. | Sessa Capital John Petry | 3,000,000 | $2,837,100 | 0.08% | |
| 4. | Millennium Management Israel Englander | 1,643,264 | $1,554,035 | 0% | |
| 5. | AQR Capital Management Cliff Asness | 1,402,210 | $1,326,069 | +20% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.05 | 90,000 | $94,797.00 | 914,359 | 2023-11-16 | Filing | |
| $1.01 | 10,000 | $10,100.00 | 824,359 | 2023-11-10 | Filing | |
| $1.03 | 148,820 | $153,805.47 | 1,340,847 | 2023-10-12 | Filing | |
| $1.08 | 342,874 | $370,783.94 | 1,192,027 | 2023-10-11 | Filing | |
| $1.14 | 508,306 | $579,367.18 | 849,153 | 2023-10-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.93 | 12,000 | $83,100.00 | 71,766 | 2021-03-15 | Filing | |
| $6.90 | 10,912 | $75,339.72 | 71,766 | 2021-03-15 | Filing | |
| $12.91 | 10,000 | $129,076.00 | 25,643 | 2018-06-08 | Filing | |
| $15.00 | 1,500 | $22,500.00 | 15,946 | 2016-06-06 | Filing | |
| $13.00 | 6,000 | $78,000.00 | 15,946 | 2016-05-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 136,180,481 | $129,371,457 | 13.91% | |
| 2. | 38,137,535 | $36,066,667 | 0% | |
| 3. | 8,851,036 | $8,373,080 | 0% | |
| 4. | 3,354,669 | $3,172,510 | 0% | |
| 5. | 2,450,400 | $2,317,343 | 0% |
News See All
10 Hot Penny Stocks to Invest in Now
CNBC reported that consumer prices rose 2.7% year-over-year in June, suggesting that President Trump's tariffs are starting to be felt across the economy.
13 Best Multibagger Stocks to Invest in Now
The global economic and geopolitical environment in 2025 is marked by uncertainty, trade tensions, and shifting monetary policies.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Lexicon Pharmaceuticals First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Lexicon Pharmaceuticals Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
10 Best Diabetes Stocks To Buy Under $10
About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income nations. Every year, diabetes directly causes 1.5 million deaths on average.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Lexicon Pharmaceuticals Third Quarter 2024 Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions].
10 Best Multibagger Penny Stocks of 2025
The term "multibagger" was coined by Peter Lynch in his book titled "One Up On Wall Street" to describe those stocks whose share prices increase several times more than an investor's original investment...
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2024 Earnings Call Transcript
Operator: Good day and welcome to Lexicon Pharmaceuticals Second Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Lexicon Pharmaceuticals First Quarter 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode.
Billionaire Hedge Funds
